Form:DrugProjectForm: Difference between revisions

Jump to navigation Jump to search
Christopher Popma (talk | contribs)
No edit summary
Christopher Popma (talk | contribs)
No edit summary
Line 17: Line 17:
|-
|-
! Please describe which indications the FDA has approved the use of the drug:
! Please describe which indications the FDA has approved the use of the drug:
| {{{field|indication|input type=textarea|size=35}}}
| {{{field|indication|input type=textarea|size=35|editor|editor}}}
|-
|-
! Is there a Black Box warning associated with the drug?:
! Is there a Black Box warning associated with the drug?:
Line 23: Line 23:
|-
|-
! Please list the most common adverse reactions associate with the drug:
! Please list the most common adverse reactions associate with the drug:
| {{{field|adverseReactions|input type=textarea|size=35}}}
| {{{field|adverseReactions|input type=textarea|size=35|editor}}}
|}
|}


Line 33: Line 33:
|-
|-
!Please enter the body of the Black Box Warning  
!Please enter the body of the Black Box Warning  
|{{{field|blackBoxWarningBody|input type=textarea|editor|size=35|default=''{{fontcolor|#FF0000|Condition Name:}}'' (Content)}}}
|{{{field|blackBoxWarningBody|input type=textarea|editor|size=35|editor|default=''{{fontcolor|#FF0000|Condition Name:}}'' (Content)}}}
|}
|}


Line 39: Line 39:
{|
{|
!Please enter the FDA-Labeled Indications and Dosage Information for Adults
!Please enter the FDA-Labeled Indications and Dosage Information for Adults
| {{{field|fdaLIADAdult|input type=textarea|size=35|default= <h4>Condition 1</h5>
| {{{field|fdaLIADAdult|input type=textarea|size=35|editor|default= <h4>Condition 1</h5>


* Dosing Information
* Dosing Information
Line 48: Line 48:
|-
|-
!Guideline-Supported Use
!Guideline-Supported Use
|{{{field|offLabelAdultGuideSupport|input type=textarea|size=35}}}
|{{{field|offLabelAdultGuideSupport|input type=textarea|size=35|editor}}}
|-
|-
!Non-Guideline-Supported Use
!Non-Guideline-Supported Use
|{{{field|offLabelAdultNoGuideSupport|input type=textarea|size=35}}}
|{{{field|offLabelAdultNoGuideSupport|input type=textarea|size=35|editor}}}
|}
|}


Line 58: Line 58:
{|
{|
!Please enter the FDA-Labeled Indications and Dosage Information for Children
!Please enter the FDA-Labeled Indications and Dosage Information for Children
| {{{field|fdaLIADPed|input type=textarea|size=35}}}
| {{{field|fdaLIADPed|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any established Off-Label Use and Dosage for Children
!Please enter any established Off-Label Use and Dosage for Children
|-
|-
!Guideline-Supported Use
!Guideline-Supported Use
|{{{field|offLabelPedGuideSupport|input type=textarea|size=35}}}
|{{{field|offLabelPedGuideSupport|input type=textarea|size=35|editor}}}
|-
|-
!Non-Guideline-Supported Use
!Non-Guideline-Supported Use
|{{{field|offLabelPedNoGuideSupport|input type=textarea|size=35}}}
|{{{field|offLabelPedNoGuideSupport|input type=textarea|size=35|editor}}}
|}
|}


Line 72: Line 72:
{|
{|
!Please enter the FDA reported contraindications:
!Please enter the FDA reported contraindications:
| {{{field|contraindications|input type=textarea|size=35}}}
| {{{field|contraindications|input type=textarea|size=35|editor}}}
|}
|}


Line 78: Line 78:
{|
{|
!Please enter the FDA reported warnings associated with the drug:
!Please enter the FDA reported warnings associated with the drug:
| {{{field|warnings|input type=textarea|size=35}}}
| {{{field|warnings|input type=textarea|size=35|editor}}}
|}
|}


Line 84: Line 84:
{|
{|
!Please enter the adverse reactions reported from Clinical Trial Experience
!Please enter the adverse reactions reported from Clinical Trial Experience
| {{{field|clinicalTrials|input type=textarea|size=35}}}
| {{{field|clinicalTrials|input type=textarea|size=35|editor}}}
|-
|-
!Please enter the adverse reactions reported from Postmarketing Experience
!Please enter the adverse reactions reported from Postmarketing Experience
|{{{field|postmarketing|input type=textarea|size=35}}}
|{{{field|postmarketing|input type=textarea|size=35|editor}}}
|}
|}


Line 93: Line 93:
{|
{|
!Please enter the known drug interactions:
!Please enter the known drug interactions:
| {{{field|drugInteractions|input type=textarea|size=35}}}
| {{{field|drugInteractions|input type=textarea|size=35|editor}}}
|}
|}


Line 99: Line 99:
{|
{|
!Please enter any information related to the FDA reported pregnancy category
!Please enter any information related to the FDA reported pregnancy category
| {{{field|useInPregnancyFDA|input type=textarea|size=35}}}
| {{{field|useInPregnancyFDA|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Australian reported pregnancy category
!Please enter any information related to the Australian reported pregnancy category
| {{{field|useInPregnancyAUS|input type=textarea|size=35}}}
| {{{field|useInPregnancyAUS|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug during Labor and Delivery
!Please enter any information related to the use of the drug during Labor and Delivery
|{{{field|useInLaborDelivery|input type=textarea|size=35}}}
|{{{field|useInLaborDelivery|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug during Nursing
!Please enter any information related to the use of the drug during Nursing
|{{{field|useInNursing|input type=textarea|size=35}}}
|{{{field|useInNursing|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Pediatrics
!Please enter any information related to the use of the drug in Pediatrics
|{{{field|useInPed|input type=textarea|size=35}}}
|{{{field|useInPed|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Geriatrics
!Please enter any information related to the use of the drug in Geriatrics
|{{{field|useInGeri|input type=textarea|size=35}}}
|{{{field|useInGeri|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug and Gender
!Please enter any information related to the use of the drug and Gender
|{{{field|useInGender|input type=textarea|size=35}}}
|{{{field|useInGender|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug and Race
!Please enter any information related to the use of the drug and Race
|{{{field|useInRace|input type=textarea|size=35}}}
|{{{field|useInRace|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in patients with Renal Impairment
!Please enter any information related to the use of the drug in patients with Renal Impairment
|{{{field|useInRenalImpair|input type=textarea|size=35}}}
|{{{field|useInRenalImpair|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in patients with Hepatic Impairment
!Please enter any information related to the use of the drug in patients with Hepatic Impairment
|{{{field|useInHepaticImpair|input type=textarea|size=35}}}
|{{{field|useInHepaticImpair|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Females of Reproductive Potential and Males
!Please enter any information related to the use of the drug in Females of Reproductive Potential and Males
|{{{field|useInReproPotential|input type=textarea|size=35}}}
|{{{field|useInReproPotential|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Immunocompromised Patients
!Please enter any information related to the use of the drug in Immunocompromised Patients
|{{{field|useInImmunocomp|input type=textarea|size=35}}}
|{{{field|useInImmunocomp|input type=textarea|size=35|editor}}}
|-
|-
!Others
!Others
|Title of Section: {{{field|othersTitle|input type=text|size=40}}}
|Title of Section: {{{field|othersTitle|input type=text|size=40}}}
Body: {{{field|useInOthers|input type=textarea|size=35}}}
Body: {{{field|useInOthers|input type=textarea|size=35|editor}}}
|}
|}


Line 142: Line 142:
{|
{|
!Please enter information pertaining to drug administration here
!Please enter information pertaining to drug administration here
| {{{field|administration|input type=textarea|size=35}}}
| {{{field|administration|input type=textarea|size=35|editor}}}
|-
|-
!Please enter information pertaining to the drug monitoring here
!Please enter information pertaining to the drug monitoring here
|{{{field|monitoring|input type=textarea|size=35}}}
|{{{field|monitoring|input type=textarea|size=35|editor}}}
|}
|}


Line 151: Line 151:
{|
{|
!Please enter information pertaining to the IV Compatibility here
!Please enter information pertaining to the IV Compatibility here
|{{{field|IVCompat|input type=textarea|size=35}}}
|{{{field|IVCompat|input type=textarea|size=35|editor}}}
|}
|}


Line 157: Line 157:
{|
{|
!Please enter information pertaining to the drug Overdose here
!Please enter information pertaining to the drug Overdose here
|{{{field|overdose|input type=textarea|size=35}}}
|{{{field|overdose|input type=textarea|size=35|editor}}}
|}
|}


Line 164: Line 164:
{|
{|
!Please enter the DrugBox template in its entirety here:
!Please enter the DrugBox template in its entirety here:
|{{{field|drugBox|input type=textarea|size=35}}}
|{{{field|drugBox|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Mechanism of Action
!Please enter any information related to the Mechanism of Action
| {{{field|mechAction|input type=textarea|size=35}}}
| {{{field|mechAction|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Structure
!Please enter any information related to the Structure
| {{{field|structure|input type=textarea|size=35}}}
| {{{field|structure|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Pharmacodynamics
!Please enter any information related to the Pharmacodynamics
|{{{field|PD|input type=textarea|size=35}}}
|{{{field|PD|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Pharmacokinetics
!Please enter any information related to the Pharmacokinetics
|{{{field|PK|input type=textarea|size=35}}}
|{{{field|PK|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Nonclinical Toxicology
!Please enter any information related to the Nonclinical Toxicology
|{{{field|nonClinToxic|input type=textarea|size=35}}}
|{{{field|nonClinToxic|input type=textarea|size=35|editor}}}
|}
|}


Line 185: Line 185:
{|
{|
!Please enter information pertaining to the Clinical Studies of the drug
!Please enter information pertaining to the Clinical Studies of the drug
|{{{field|clinicalStudies|input type=textarea|size=35}}}
|{{{field|clinicalStudies|input type=textarea|size=35|editor}}}
|}
|}


Line 191: Line 191:
{|
{|
!Please enter information pertaining to the How the Drug is Supplied
!Please enter information pertaining to the How the Drug is Supplied
|{{{field|howSupplied|input type=textarea|size=35}}}
|{{{field|howSupplied|input type=textarea|size=35|editor}}}
|-
|-
!National Drug Code (NDC):
!National Drug Code (NDC):
Line 209: Line 209:
{|
{|
!Please enter information pertaining to the Drug Images here
!Please enter information pertaining to the Drug Images here
|{{{field|drugImages|input type=textarea|size=35}}}
|{{{field|drugImages|input type=textarea|size=35|editor}}}
|-
|-
!Please enter information pertaining to the FDA Package Label here
!Please enter information pertaining to the FDA Package Label here
|{{{field|packLabel|input type=textarea|size=35}}}
|{{{field|packLabel|input type=textarea|size=35|editor}}}
|}
|}


Line 253: Line 253:
{|
{|
!Please enter the FDA Provided Patient Information here
!Please enter the FDA Provided Patient Information here
|{{{field|fdaPatientInfo|input type=textarea|size=35}}}
|{{{field|fdaPatientInfo|input type=textarea|size=35|editor}}}
|-
|-
!Please enter the NLM Provided Patient Information Here
!Please enter the NLM Provided Patient Information Here
|{{{field|nlmPatientInfo|input type=textarea|size=35}}}
|{{{field|nlmPatientInfo|input type=textarea|size=35|editor}}}
|}
|}


=Precautions with Alcohol=
=Precautions with Alcohol=
Please describe any guidelines on the concurrent use of the drug with the consumption of alcohol:
Please describe any guidelines on the concurrent use of the drug with the consumption of alcohol:
{{{field|alcohol|input type=textarea|size=35}}}
{{{field|alcohol|input type=textarea|size=35|editor}}}


=Look-Alike Drug Names=
=Look-Alike Drug Names=
Please enter any drug names that could be confused for the drug whose page is currently being created.
Please enter any drug names that could be confused for the drug whose page is currently being created.
{{{field|lookAlike|input type=textarea|size=35}}}
{{{field|lookAlike|input type=textarea|size=35|editor}}}


=Price=
=Price=
{|
{|
!Please enter the drugs a patient may want to compare for Price
!Please enter the drugs a patient may want to compare for Price
|{{{field|price|input type=textarea|size=35}}}
|{{{field|price|input type=textarea|size=35|editor}}}
|}
|}


Line 276: Line 276:
{|
{|
!Please enter information relevant to Drug Shortages
!Please enter information relevant to Drug Shortages
|{{{field|drugShortage|input type=textarea|size=35}}}
|{{{field|drugShortage|input type=textarea|size=35|editor}}}
|}
|}



Revision as of 20:51, 2 April 2014